Literature DB >> 1089142

Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy.

A J McAdams, P T McEnery, C D West.   

Abstract

In all of eight patients with mesangiocapillary glomerulonephritis who received prednisone in an alternate-day schedule for 3 to 9 hr, the glomerule showed a marked reduction in mesangial cellularity and complete regression of mesangial interposition. Subendothelial deposits disappeared but intramembranous dense deposits, when present previously, persisted. Repair was incomplete in that a few mesangial deposits were still present, immunoflourescence was unchanged, and several of the patients developed focal mesangial scarring and increased numbers of global bodies. Functional glomerule and glomerular tuft segments, however, showed greatly improved morphology. There was no evidence of deterioration of renal function over a follow-up period of 5 to 11.5 yr.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089142     DOI: 10.1016/s0022-3476(75)80699-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  Efficacy of school urinary screening for membranoproliferative glomerulonephritis type 1.

Authors:  Y Kawasaki; J Suzuki; R Nozawa; H Suzuki
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

2.  Screening for renal disease in school children: experience in Japan.

Authors:  T Kitagawa
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

3.  Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  Teruo Fujita; Kandai Nozu; Kazumoto Iijima; Ichiro Kamioka; Kunihiko Yoshiya; Ryojiro Tanaka; Kiyoshi Hamahira; Koichi Nakanishi; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

4.  Transition of children with membranoproliferative glomerulonephritis to adolescence and adulthood.

Authors:  Kikuo Iitaka; Osamu Motoyama; Shinya Nakamura; Hiroe Koshino; Tadasu Sakai
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

5.  Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.

Authors:  S J Chapman; J S Cameron; C Chantler; D Turner
Journal:  Arch Dis Child       Date:  1980-06       Impact factor: 3.791

Review 6.  Lessons learned from the Japanese nephritis screening study.

Authors:  T Kitagawa
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

Review 7.  The treatment of glomerulonephritis in children.

Authors:  G B Haycock
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

8.  Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  M Somers; S Kertesz; S Rosen; J Herrin; R Colvin; N Palacios de Carreta; M Kim
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

9.  Inhibition of immune complex solubilization by sera of patients with membranoproliferative glomerulonephritis.

Authors:  T R Welch; A Kleesattel; L Beischel
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

10.  Idiopathic membranoproliferative glomerulonephritis in Japanese children.

Authors:  K Iitaka; T Ishidate; M Hojo; S Kuwao; N Kasai; T Sakai
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.